HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas
Cancers · 20.04.2024 · 16 (8) · 1584
DOI: 10.3390/cancers16081584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 20.04.2024. Verfasst von Xavier Sastre-Garau und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Centre Hospitalier Intercommunal de Créteil, 40, Avenue de Verdun, 94010 Créteil, France. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In HPV-associated carcinomas, some examples of cancer-related genes altered by viral insertion and corresponding to potential therapeutic targets have been described, but no quantitative assessment of these events, including poorly recurrent targets, has been reported to date. To document these occurrences, we built and analyzed a database comprised of 1455 cases, including HPV genotypes and tumor localizations. Host DNA sequences targeted by viral integration were classified as “non-recurrent” (one single reported case; 838 loci), “weakly recurrent” (two reported cases; 82 loci), and highly recurrent (≥3 cases; 43 loci). Whereas the overall rate of cancer-related target genes was 3.3% in the Gencode database, this rate increased to 6.5% in “non-recurrent”, 11.4% in “weakly recurrent”, and 40.1% in “highly recurrent” genes targeted by integration (p = 4.9 × 10−4). This rate was also significantly higher in tumors associated with high-risk HPV16/18/45 than other genotypes. Among the genes targeted by HPV insertion, 30.2% corresponded to direct or indirect druggable targets, a rate rising to 50% in “highly recurrent” targets. Using data from the literature and the DepMap 23Q4 release database, we found that genes targeted by viral insertion could be new candidates potentially involved in HPV-associated oncogenesis. A more systematic characterization of HPV/host fusion DNA sequences in HPV-associated cancers should provide a better knowledge of HPV-driven carcinogenesis and favor the development of personalize patient treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Centre Hospitalier Intercommunal de Créteil, 40, Avenue de Verdun, 94010 Créteil, France.
- Institut Curie, PSL Research University, CNRS, UMR 144, 75005 Paris, France.
ORCID-Profile: François Radvanyi
Zitieren
APA
Sastre-Garau, X., Estrada-Virrueta, L., & Radvanyi, F. (2024). HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas. Cancers, 16(8), 1584. https://doi.org/10.3390/cancers16081584
Vancouver
Sastre-Garau X, Estrada-Virrueta L, Radvanyi F. HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas. Cancers. 2024;16(8):1584. doi:10.3390/cancers16081584
BibTeX
@article{SastreGarau2024,
author = {Sastre-Garau, Xavier and Estrada-Virrueta, Lilia and Radvanyi, François},
title = {HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas},
journal = {Cancers},
year = {2024},
volume = {16},
number = {8},
pages = {1584},
doi = {10.3390/cancers16081584}
}
EUVIMED